KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $748,000 | +68.1% | 4,207 | -2.0% | 0.04% | +63.6% |
| Q2 2017 | $445,000 | +55.1% | 4,292 | +17.5% | 0.02% | +57.1% |
| Q1 2017 | $287,000 | +20.6% | 3,654 | -29.7% | 0.01% | -12.5% |
| Q1 2016 | $238,000 | -71.2% | 5,200 | -61.2% | 0.02% | -71.4% |
| Q4 2015 | $825,000 | +10.6% | 13,400 | 0.0% | 0.06% | +5.7% |
| Q3 2015 | $746,000 | -8.6% | 13,400 | 0.0% | 0.05% | -1.9% |
| Q2 2015 | $816,000 | +36.2% | 13,400 | +28.8% | 0.05% | +38.5% |
| Q1 2015 | $599,000 | – | 10,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |